Aquestive Therapeutics
AQST
#6502
Rank
ยฃ0.55 B
Marketcap
ยฃ4.59
Share price
-7.85%
Change (1 day)
50.32%
Change (1 year)

Revenue for Aquestive Therapeutics (AQST)

Revenue in 2025 (TTM): ยฃ33.01 Million

According to Aquestive Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ32.63 Million. In 2024 the company made a revenue of ยฃ45.86 Million an increase over the revenue in the year 2023 that were of ยฃ39.7 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aquestive Therapeutics from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ33.01 M-28.02%
2024 ยฃ45.86 M15.53%
2023 ยฃ39.7 M0.74%
2022 ยฃ39.41 M4.66%
2021 ยฃ37.65 M11.95%
2020 ยฃ33.63 M-16.16%
2019 ยฃ40.11 M-24.48%
2018 ยฃ53.12 M7.28%
2017 ยฃ49.51 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
ยฃ0.16 M-99.48%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.48 B 1,379.52%๐Ÿ‡บ๐Ÿ‡ธ USA